Twenty-four-hour urine specimens were collected daily from a rapidly cycling manic-depressive patient throughout a 3-month hospitalization, and were analyzed for volume, osmolality, creatinine, 17-OHCS, and VMA. Mean 17-OHCS excretion was significantly greater during depression than during hypomania, but only in the latter half of hospitalization, after the patient had become acclimatized to the hospital. Mean VMA excretion was significantly increased only during the period of hypomania when the patient was physically active. The 17-OHCS data suggest that interaction between stressful environmental stimuli and intrapsychic ego-defense strength determines the adrenal-cortical activity level during any given phase of the manic-depressive cycle. The VMA data are in accord with previous studies of catecholamine excretion in cyclic affect disorders.
Twenty-four-hour urine specimens were collected daily from a rapidly cycling manic-depressive patient throughout a 3-month hospitalization, and were analyzed for volume, osmolality, creatinine, 17-OHCS, and VMA. Mean 17-OHCS excretion was significantly greater during depression than during hypomania, but only in the latter half of hospitalization, after the patient had become acclimatized to the hospital. Mean VMA excretion was significantly increased only during the period of hypomania when the patient was physically active. The 17-OHCS data suggest that interaction between stressful environmental stimuli and intrapsychic ego-defense strength determines the adrenal-cortical activity level during any given phase of the manic-depressive cycle. The VMA data are in accord with previous studies of catecholamine excretion in cyclic affect disorders. AN RECENT YEARS many psychoendocrine studies have utilized a longitudinal sampling methodology in which biochemical measures are made repeatedly on a small number of patients. Longitudinal sampling, in contrast to crosssectional methodology, permits intraindividual comparison of endocrine measures during different phases of many types of stress states. For longitudinal studies, manic-depressive illness 163 production and excretion during depression and reduction during mania. 1 Gibbons and McHugh-showed higher plasma 17-OHCS levels during depression than during elation. On the other hand, Bliss et al. a found higher plasma 17-OHCS levels during periods of manic overactivity. Studies of urinary corticoid excretion have been somewhat more uniform in their results: Rizzo et ed.,* Bryson and Martin, 5 Kurland, 6 -7 and Bunney et a/. 8 ' 9 have all demonstrated greater 24-hr, excretion of 17-OHCS or 17-ketosteroids during the depressive phases of manic-depressive illness. These studies were done on male and female patients, whose ages ranged from 14 to 50 years, with cycle lengths of 48 hr. to over 1 year.
Studies of catecholamine metabolism in manic-depressive illness have generally shown urinary excretion of epinephrine and norepinephrine to be greater during manic phases than during depression. 10 A longitudinal study by StromOlsen and Weil-Malherbe 11 showed increased excretion of both epinephrine and norepinephrine during mania. A study by Bergsman 12 also showed increased epinephrine and norepinephrine excretion during mania, but the greatest change between the manic and depressive phases in the same patient was in epinephrine excretion. Shinfuku 13 confirmed the finding of increased epinephrine and norepinephrine excretion during mania in a rapidly cycling manic-depressive but, in contrast to Bergsman, 12 found that the greatest change between manic and depressive phases was in norepinephrine excretion. Schildkraut et al. u -15 demonstrated increased normetanephrine and metanephrine excretion during mania, as did Nelson et al. w The increases in all these urinary catecholamine metabolites have been considered reflections of increased peripheral sympathetic and perhaps central nervous system activity in mania, possibly a concomitant of exaggerated motor activity.
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There appear, however, to be no previous longitudinal studies of the excretion of VMA, the major urinary metabolite of epinephrine and norepinephrine, 18 in manic-depressive illness. It has been suggested that measurement of VMA excretion may be a useful index of epinephrine and norepinephrine biosynthesis.
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Subject and Methods M.B., a 34-year-old Caucasian housewife, had a 4-year history of cyclic mood changes with an initial periodicity of 4 months. These mood changes had begun after the birth of her third child. The frequency of the cycles had increased, and during this study the cycle length was approximately 4 weeks. She had been married for 9 years to an administrator for an aircraft company. The marriage had been initially happy for both, but there had been continual friction after the patient developed mood swings. During the hypomanic phases the patient felt wonderful, busied herself around the ward and in occupational therapy, looked cheerful, and was extremely talkative with some loosening of associations. During these phases the patient returned from weekend home visits with suspicious ideation about her husband -he was threatening to kill her, he had accused her of having sexual relations with her doctors, etc. Her husband did admit to having been short with her during these visits, but just how much he threatened her was never completely ascertained. During these phases they both talked intermittently of divorce. She ate well, slept from 4 to 6 hr. a night, and was generally no management problem, being quite cooperative.
During the depressive phases the patient evidenced moderate psychomotor retardation and appeared depressed; Veraguth's folds appeared. She spent most of her time sitting in the day room, responding to questions but initiating no conversation. Her comments centered around the hopelessness of her illness and her marriage, but again, she was indecisive about divorce. During her first hypomanic phase she was found to be about 8 weeks pregnant; she remained pregnant throughout the study. During her entire hospital stay she received no antipsychotic, antianxiety, or antidepressant medications, or ECT. Management consisted solely of milieu and occupational therapies and frequent, brief contacts with ward physicians.
The clinical status of the patient was determined from doctors' and nurses' objective ratings. The head nurse, who had no knowledge of the laboratory data, rated the patient daily as hypomanic, euthymic, or depressed, after discussion with nursing staff and review of each day's nurses' and physicians' notes. Daily 24-hr, urine specimens were collected, with 8 A.M. as the time of change. The urine was pooled in the refrigerator at 4°C. on the collection day and immediately frozen at -20° C. after the specimen was complete. Urine osmolality was measured on a Fiske osmometer. Creatinine was determined by the standard method of Jaffe; 20 17-OHCS, by a modified method of Silber and Porter; 2122 and VMA, by the method of Pisano et al. 23 The means and standard deviations of urine volume, osmolality, creatinine, 17-OHCS, and VMA were determined for total days of hypomania, euthymia, and depression as well as for the individual phases (3 of hypomania, 2 of euthymia and 2 of depression). For all clinical phases, 2-tailed t tests of significance between means were done on each variable measured. Differences at the 0.05 or less level were considered significant. Correlation coefficients and their significance levels were determined for each variable compared to each of the others over the 90-day period. In addition, run tests for randomness of sampling 24 were done on each variable measured, for all clinical phases. In no run test did the critical values exceed the 0.05 level; this result indicates random sampling during every phase.
Results Figure 1 shows a graph of the clinical periods and all urine variables measured. In some instances the discrete phases are separated by 2 or 3 days of euthymia, this being important for the 2 juxtaposed hypomanic phases, which are characterized by differing biochemical patterns. Trends of increasing urine volume and creatinine excretion, decreasing osmolality and 17-OHCS excretion, and fairly constant VMA excretion throughout the 90-day period are apparent. Figure 2 shows a matrix of correlation coefficients and their significance levels for each biochemical variable. As would be expected, osmolality correlated negatively with volume and creatinine, and volume correlated positively to a high degree with creatinine. The 17-OHCS did not correlate to a significant degree with volume, osmolality, or creatinine. VMA, on the other hand, correlated positively to a moderate degree with volume and creatinine and to some degree with 17-OHCS. These correlation coefficients suggest that changes in urine 17-OHCS excretion and in urine volume were relatively independent, whereas changes in VMA excretion may have been partially influenced by changes in urine volume.
Dawson and Bone 25 have reported a positive correlation between urine volume and excretion of both epinephrine and norepinephrine in psychotic patients.
However, since a significant change in mean VMA excretion occurred in our patient only during the second period of hypomania, which was not when urine volume changed significantly, any dayto-day influences that the changing urine volume had on VMA excretion must have been subtle. Table 1 lists the clinical periods, number of days of each, and the means and standard deviations of each variable measured. Figures 3-7 show matrices of t tests of the differences between means for each variable for each clinical period, compared with the other clinical periods. In addition, means, standard deviations, and t tests of differences between means of each variable are shown for total days of hypomania, euthymia, and depression. These latter data include the days between clinical periods as well as the discrete clinical periods themselves.
With reference to the first 3 variables (Table 1 and Fig. 3-5 ), mean urine volume and creatinine were significantly lower and mean osmolality was significantly higher during the first period of euthymia (euthymiai) compared with all subsequent periods, with no consistent mean differences among the subsequent periods themselves. The values for these 3 variables during euthymiai are the major factors contributing to the significant mean differences noted between total days of euthymia and total days of hypomania and depression. With reference to urine 17-OHCS (Table 1 and Fig. 6 ), there was a significantly greater mean excretion for total days of depression than for total days of both hypomania and euthymia. However, mean 17-OHCS excretions during the first periods of euthymia, hypomania and depression (in the first half of the patient's hospitalization) were not significantly different; only during the second half of her hospitalization, during the second and third periods of hypomania, were mean 17-OHCS excretions significantly lower than during the first period of hypomania and both periods of depression.
With reference to urine VMA (Table  1 and Fig. 7) , there was a significantly greater mean excretion for total days of hypomania than for both total days of euthymia and total days of depression. This increase primarily reflects a VMA excretion significantly greater during the second period of hypomania than during the other periods of hypomania, euthymia, and depression. Our patient showed significantly decreased urine volume and creatinine and significantly increased osmolality during euthymiai (at the beginning of hospitalization); there were no consistent changes during 3 periods of hypomania and 2 of depression subsequent to euthymiai. Urine volume was significantly lower during depression! than during hypomanias; osmolality was significantly higher during depression! than during depression. These results are at some variance from previously reported studies of water and electrolyte excretion in affect disorders. Schottstaedt et al.-e noted decreased urinary excretion of water, sodium, and potassium (5-hr, samples) during episodes of reduced physical activity, attitudes of futility or hopelessness, and feelings of depression or exhaustion in otherwise normal subjects. Water, sodium, and potassium intake varied considerably during these episodes. Crammer 27 studied 2 manic depressives, 1 with 6-week cycles and 1 with 6-to 7-day cycles. In both patients, 24-hr, urinary excretion of water and sodium was lower during depression than during mania, while creatinine excretion remained stable. Reduction of water and sodium intake in the second patient altered excretion patterns considerably. (Other investigations of mineral metabolism in affective disorders have included measurements of water and sodium in body compartments 28 but are not directly applicable to this study.)
In our patient the mean differences in urine volume, osmolality, and creatinine during euthymiai may be explained on the basis of reduced water intake during this period. When hypomania 2 started, the patient's water intake increased; during the rest of her hospital stay, it remained at a fairly constant level. Uncontrolled variations in water and sodium intake may explain the differences in urinary excretion in manic-depressives, as reported in this and other studies. 28 ' 27 The stability of urinary creatinine excretion in our patient after euthymiai agrees with Crammer's findings.-' 7 Creatinine excretion is less susceptible than water and sodium excretion to day-today fluctuations in diet, and is determined primarily by breakdown of muscle protein, although influenced by dietary intake of creatine in meat. In our patient creatinine excretion correlated highly positively (-|-.88) with water excretion-both were stable after euthymiai. In another rapidly cycling manic-depressive patient in our series, daily urinary excretion of creatinine and water in a 3-month period (13» cycles) also correlated positively (+.61). 29 In Crammer's patients, however, creatinine excretion was stable, and water excretion fluctuated, and inspection of the data in his paper suggests a low correlation for these 2 variables. Cramer et al. 80 studied the twenty-four-hr. urinary excretion of creatinine and water in 35 patients with lead poisoning, with observation times of 7 to 41 days. In all, the serum creatinine level was normal, and there was no proteinuria or glycosuria. Correlation coefficients ranged from +.80 to -.49, with 21 of the 35 values being between +.60 and +.20. Thus, the degree of positive correlation of creatinine with water excretion appears to be a highly individual factor.
17-OHCS
In our patient, the over-all mean urinary 17-OHCS excretion was greater during depression than during hypomania-a result that agrees with previous studies. The intrapsychic mechanism postulated as an explanation for heightened adrenal-cortical activity is that during depressive phases there is lessened denial, increased awareness of illness, and increased "felt" anxiety. In our patient however, differences in 17-OHCS VOL. XXX, NO. 2, 1968 excretion between individual cycle phases appeared only in the latter half of hospitalization, being a lower mean excretion during hypomania 2 and hypomanias than during hypomaniai, depression,, and depressions. This finding suggests that a heightened defensiveness during hypomania, relative to depression, influenced 17-OHCS excretion only after the patient had acclimatized to hospital, and, further suggests that environmental stimuli interact with intrapsychic defenses to determine the level of adrenal-cortical activity during any given cycle phase in manic-depressive illness.
Environmental influences on adrenalcortical activity in depressed patients have been noted previously. Anderson and Dawson 31 found that a group of depressed patients newly hospitalized on an admission ward had higher mean plasma 17-OHCS levels than a similar group of depressed patients newly hospitalized on a research ward. Sachar et al. S2 reported increases in urinary 17-OHCS excretion in depressed patients when, during psychotherapy, they were actively confronted, and forced to deal, with the antecedent disappointment or loss. Also, a third, rapidly cycling manicdepressive patient in our series was studied during 2 periods of hospitalization approximately 3 years apart. 28 Her illness was clinically identical during both hospitalizations. During the first hospitalization, peaks of urinary 17-OHCS excretion occurred approximately 9 days apart throughout both manic and depressive phases, with no significant difference in mean excretion values between phases. These peaks were associated with "milieu crisis" days on the ward. 33 During the second hospitalization (in the same hospital but on a different ward, one with a verv different milieu) the milieu crises and concomitant peaks of 17-OHCS excretion did not occur, and her over-all mean 17-OHCS excretion pattern was similar to that reported for the patient in this study. (During her second hospitalization she was on the same ward and had contact with the same personnel as had the patient reported in this study.) All these data considered together provide further evidence that both the level of stressful environmental stimuli and the amount of intrapsychic ego-defense strength are important determinants of the adrenal response in manic-depressive illness.
VMA
In our patient, the over-all increase in mean urinary VMA excretion during hypomania is in agreement with previous studies of other catecholamine metabolites. However, with respect to the individual cycle phases, VMA excretion increased significantly only during hypomania 2 . During this period the patient showed a greater level of motor activity than during the other 2 periods of hypomania. She was in open competition with a male patient for the ward presidency and had several physical encounters with nursing staff. These encounters were not severe, consisting mainly of nursing staffs' restraining her from walking off the unlocked ward by leading her away from the ward door, but they occurred only during hypomania 2 . The increased mean VMA excretion during this period may be a reflection of this heightened motor activity.
Effects of Pregnancy
Our patient was studied during the first 4 months of a normal pregnancy. Previous studies on the urinary excretion of creatinine, 17-OHCS, and catecholamines have indicated no significant changes in mean excretion values during normal pregnancy. Clark et al. 3 * measured 24-hr, urinarv creatinine in 280 samples from 36 subjects during uncomplicated pregnancy. Creatinine excretion was constant during all 3 trimesters. Our patient learned she was pregnant on June 14, during hypomaniai, and had a 1-day peak of 17-OHCS at that time (Fig. 1) . Although bound plasma cortisol increases during pregnancy because of increased concentration of plasma protein, the adrenal-secretion rate and 24-hr, urine 17-OHCS are not affected by pregnancy per se. 35 Likewise, studies of catecholamines have shown no significant changes in plasma levels 36 or in rate of urinary excretion 37 of epinephrine and norepinephrine during the last trimester of pregnancy. However, the performing of housework and other physical activities by pregnant women has been noted to result in increased urinary excretion of these catecholamines. It is thus likely that the patient's being pregnant throughout this study is in itself not significant in the interpretation of the creatinine, 17-OHCS, and VMA findings. It is of interest that during the clinically juxtaposed second and third periods of hypomania, mean 17-OHCS excretions were the same, whereas mean VMA excretions were significantly different. From these data it appears that hypomanic phases of manic-depressive illness in the same patient may be characterized by differing patterns of physiologic activity, at least as reflected in the urinary excretion of glucocorticoid and catecholamine metabolites.
Summary
Longitudinal psychoendocrine studies of manic-depressive patients have revealed significant elevations in the urinary excretion of 17-OHCS during depression compared with mania. The intrapsychic mechanism postulated as an explanation is that during depression there is increased "felt" anxiety, whereas during mania there is a relative feeling of well-being. The increased corticosteroid excretion in the depressive phases is considered to be a concomitant of VOL XXX, NO. 2. 1968 lowered ego-defense strength and increased "felt" anxiety. Recent studies suggest that environmental variables are important in this steroid response, both milieu aspects and psychotherapeutic confrontations being influential factors. Therefore, both the level of stressful environmental stimuli and the amount of intrapsychic ego-defense strength appear to be determinants of the adrenal response. Our study supports this hypothesis.
Studies of catecholamine metabolism have shown the urinary excretion of epinephrine and norepinephrine to be greater during mania than during depression. These increases have been considered reflections of exaggerated motor activity, with increased activity of the peripheral sympathetic nervous system.
In this investigation a 34-year-old, married, Caucasian female manic-depressive patient was studied during a 3-month hospitalization, with no treatment, through 3 episodes of hypomania, 2 episodes of euthymia, and 2 episodes of depression. Total 24-hr, urine collections were made for the entire period and the urine was analyzed for volume, osmolality, creatinine, 17-OHCS, and VMA, the major urinary catecholamine metabolite.
Mean daily excretion of 17-OHCS for all days of depression was significantly higher than the means for both all days of hypomania and all days of euthymia. Mean daily 17-OHCS excretion during periods of both depression and hypomania at the beginning of hospitalization were not significantly different, but 17-OHCS excretion during 2 subsequent periods of hypomania was significantly lower than that during a subsequent period of depression. This finding correlated with the increasing familiarity of the patient with hospital surroundings. Mean daily VMA excretion for all days of hypomania was significantly higher than the means for both all days of euthymia and all days of depression.
The steroid data suggest that both ego-defense strength and stressful environmental stimuli interact in influencing the adrenal response in manic-depressive illness. The VMA data are in agreement with previous catecholamine studies in cyclic affect disorders.
